US FDA refuses to review Zogenix's seizure treatment

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

REUTERS: The U.S. Food and Drug Administration on Monday refused to review the marketing application for Zogenix Inc's treatment for seizures ...

I consent to the use of my personal data by Mediacorp and the Mediacorp group of companies to send me marketing and advertising materials in relation to goods and services of Mediacorp and its business partners and for research and analysis.

I consent to the use of my personal data by Mediacorp and the Mediacorp group of companies to send me marketing and advertising materials in relation to goods and services of Mediacorp and its business partners and for research and analysis
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US FDA approves GSK's two-drug HIV treatmentThe U.S. Food and Drug Administration said on Monday it had approved GlaxoSmithKline Plc's two-drug HIV treatment.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

IVF tied to slight increased risk of rare childhood cancers(Reuters Health) - Certain rare childhood cancers may be more common in children conceived via in vitro fertilization (IVF), a U.S. study ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Most parents would support age restrictions for tackle football(Reuters Health) - Even though there are no age restrictions on tackling in youth football in the U.S., a new survey suggests most parents would ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »